Sort
15,273 grants matching “antimicrobial resistance”
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
$868,077Paul Stephen Keim · Translational Genomics Research Inst · R01 · FY2014 · AI
Neuregulin-4: A Novel Therapy for Inflammatory Bowel Disease
$867,924Soumitra Ghosh · Avexegen Therapeutics, Inc. · R44 · FY2021 · DK
Programmable benchtop bioreactors for scalable eco-evolutionary dynamics of the human microbiome
$867,648Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2022 · AI
Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus
$867,235Gordon H Williams · Brigham And Women'S Hospital · R01 · FY2008 · HL
Therapeutic Development of Antimicrobial Biomimetics
$867,200Richard W Scott · Polymedix, Inc, · R44 · FY2008 · AI
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms
$867,033Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Rapid ID and AST Directly from Whole Blood Using Single Molecule Detection
$866,840Alfredo Andres Celedon · Scanogen, Inc. · R01 · FY2023 · AI
Innate, Transcriptomic, and Microbiomic correlates of TB infection
$866,176Michael Haggai Glickman · Weill Medical Coll Of Cornell Univ · U19 · FY2020 · AI
Fluorescence Enhanced Photothermal Infrared Spectroscopy (FE-PTIR) - breakthrough for simultaneous fluorescence microscopy and sub-micron IR spectroscopy
$865,376Craig Prater · Photothermal Spectroscopy Corp. · R44 · FY2022 · GM
Integrated Multi-omics of Melioidosis
$864,642Timothy Eoin West · University Of Washington · R01 · FY2020 · AI
Epidemiology and Etiology of Hospitalized Pneumonia in Children
$864,291Krow Ampofo · University Of Utah · U18 · FY2009 · IP
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea
$862,755Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis
$862,493Yow-Pin Lim · Prothera Biologics, Llc · R44 · FY2020 · AI
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
$862,400Scott E. Evans · University Of Tx Md Anderson Can Ctr · R35 · FY2024 · HL
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$862,362Alice S Prince · Columbia University Health Sciences · R35 · FY2022 · HL
Fluorescence Enhanced Photothermal Infrared Spectroscopy (FE-PTIR) - breakthrough for simultaneous fluorescence microscopy and sub-micron IR spectroscopy
$861,541Craig Prater · Photothermal Spectroscopy Corp. · R44 · FY2023 · GM
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$861,458Alice S Prince · Columbia University Health Sciences · R35 · FY2021 · HL
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$861,202Alice S Prince · Columbia University Health Sciences · R35 · FY2020 · HL
Mechanisms of Chromosome Maintenance in Bacteria
$861,097Dhruba K Chattoraj · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Expanding small molecule functional metagenomics through shuttle BAC expression i
$861,013Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2015 · AI
Hybrid Antibiotics for Persistent Infections
$860,889Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2023 · AI
Task C03: Non-GMP manufacturing of a compound with activity against gram negative bacteria
$860,167Melissa Allard · Albany Molecular Research, Inc. · N01 · FY2019 · AI
Novel broad spectrum therapeutic glycans against Category B pathogens
$858,575David S Newburg · Massachusetts General Hospital · U01 · FY2008 · AI
Gene Regulation In The Immune System
$857,846Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
A general mechanism of persister formation
$857,014Kim Lewis · Northeastern University · R01 · FY2019 · AI